MycoWorks Receives Investment from GM Ventures
Summary
MycoWorks, a San Francisco, CA-based biotechnology company, received an investment from GM Ventures, the investment arm of General Motors Co. (NYSE: GM). The amount of the deal was not disclosed. The company intends to use the funds to advance its R&D efforts and build more sustainable alternatives for their designers. Founded in 2013 by Philip Ross and Sophia Wang, and led by Matt Scullin, CEO, MycoWorks is a biomaterials company dedicated to bringing new mycelium materials to the world. Its patented Fine Mycelium technology, a manufacturing platform and innovation in materials science, engineers mycelium during growth to form proprietary, interlocking cellular structures for increased strength and durability.
Funding
Amount
-
Total raised
Date
-
Announcement date
Investors
General Motors Ventures
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected